Profile
BJDX ABT BSX-PA SYK MDT BSX
Company Name Bluejay Diagnostics, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $1.54M $192.90B $175.45B $137.02B $131.98B $113.11B
Employees 0.01K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Indranil Dey Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
BJDX ABT BSX-PA SYK MDT BSX
Quant Rating Score 3 2 3 3 1
Quant Rating Neutral Sell Neutral Neutral Strong Sell
Trading
BJDX ABT BSX-PA SYK MDT BSX
Last Close $1.43 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $7.5 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $1.3 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -80.93 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 10 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
BJDX ABT BSX-PA SYK MDT BSX
1 Month Return -44.57 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 2.88 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return -20.11 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return -58.06 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -70.64 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -55.86 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BJDX ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.17 % - 0.95 % 2.75 % -
Dividend Paid and Capex Coverage Ration (TTM) -5638.25 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
BJDX ABT BSX-PA SYK MDT BSX
Asset Growth 36.74 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth 74.51 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth - 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year - 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year - 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year - 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth 30.73 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth 22.46 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share -41.83 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share -340.65 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share -340.65 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth 30.47 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) 5.94 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG -22.74 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG -100.17 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG -100.17 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth -57.24 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth -57.24 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share 47.92 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share -80.73 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share 184.53 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share 184.53 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share -100 % 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth -37.04 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth 9.89 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
BJDX ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM -6.4 % 55.51 % 65.05 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -140.09 % 7.75 % 6.53 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -147.49 % 13.18 % 12.42 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -186.45 % 11.56 % 8.97 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 100 % 77.06 % 85.26 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 98.21 % 105.19 % 97.5 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -3228.28 % 18.16 % 17.33 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -4431.99 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM - 4.26 6.84 6.22 5.44 7.1
Payables Turnover TTM 1.43 4.78 6.75 - 5.08 6.21
Inventory Turnover TTM - 2.94 2.32 1.72 2.13 2.13
Fixed Asset Turnover TTM 14.14 % 385.33 % 451.15 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 4.42 % 52.66 % 45.31 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -16.1 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -16.1 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 783.03 % 442.64 % 86.05 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -2932.81 % 20.57 % 23.91 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.02 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -4431.99 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -0.24 27.89 35.99 31.99 25.35 29.96
Price To Operating Cash Flows Ratio TTM -0.21 21.23 29.35 27.17 18.54 24.45
Price Cash Flow Ratio TTM -0.21 21.23 29.35 27.17 18.54 24.45
Income Statement (TTM)
BJDX ABT BSX-PA SYK MDT BSX
Revenue $0B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $-0B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 0% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.01B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -456.76 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
BJDX ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.01B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
BJDX ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.01B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 111.08
ADGM Adagio Medical Holdings, Inc. 0.9851
AEMD Aethlon Medical, Inc. 2.22
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.72
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 192.59
ALUR Allurion Technologies Inc. 1.08
AMIX Autonomix Medical, Inc. Common Stock 0.4031
ANIK Anika Therapeutics, Inc. 10.25
AORT Artivion, Inc. 39.6
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 4.085
ARAY Accuray Incorporated 0.57
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.505
AVNS Avanos Medical, Inc. 14.24
AVR Anteris Technologies Global Corp. Common Stock 5.605
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to BJDX
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 219.57
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0 408.25
Unlock